Skip to content

SOFARMEX: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

SOFARMEX

BE 0654.747.129
NACE 21.209, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2026 compared with 2025filed annual accounts (NBB)
Net result for the year
€2.5m
2025 · €2.0m+€498,478
Equity
€4.5m
2025 · €2.0m+€2.5m
Cash
-
not filed
Balance sheet total
€5.2m
2025 · €2.6m+€2.7m

Largest movements

2025 to 2026
Assets
  • Stocks and contracts +€1.8m

    up €1.8m (+274%), from €647,729 to €2.4m

  • Receivables within one year +€886,435

    up €886,435 (+46.0%), from €1.9m to €2.8m

    of which Other amounts receivable: +€1.7m

Equity and liabilities
  • Profit (loss) carried forward +€2.5m

    up €2.5m (+121%), from €2.0m to €4.5m

  • Trade debts +€305,966

    up €305,966 (+70.7%), from €432,536 to €738,502

  • Other debts -€100,473

    no longer reported in 2026 (was €100,473)

Income statement
  • Turnover +€2.7m

    up €2.7m (+9.8%), from €27.4m to €30.0m

  • Goods and materials +€1.8m

    up €1.8m (+7.9%), from €22.6m to €24.4m

    of which Purchases: +€3.0m

  • Services and other goods +€304,864

    up €304,864 (+14.5%), from €2.1m to €2.4m

From the 2025 result to the 2026 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2025 €2.0m
Turnover +€2.7m
Goods and materials -€1.8m
Services and other goods -€304,864
Write-downs +€14,579
Other operating charges -€182
Financial income +€20,274
Financial charges +€30,093
Taxes -€166,108
Result 2026 €2.5m
raises the resultlowers the result

Derived cash bridge

cash 2025 to 2026

Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.

Every line side by side 44 lines
Line Code 2025 2026 Change %
Total assets 20/58 €2,576,349 €5,234,932 +€2.7m +103%
Current assets 29/58 €2,576,349 €5,234,932 +€2.7m +103%
Stocks and contracts in progress 3 €647,729 €2,419,877 +€1.8m +274%
Stocks 30/36 €647,729 €2,419,877 +€1.8m +274%
Goods purchased for resale 34 €647,729 €2,419,877 +€1.8m +274%
Amounts receivable within one year 40/41 €1,928,620 €2,815,055 +€886,435 +46.0%
Trade receivables 40 €1,482,156 €627,757 -€854,399 -57.6%
Other amounts receivable 41 €446,464 €2,187,298 +€1.7m +390%
Total equity and liabilities 10/49 €2,576,349 €5,234,932 +€2.7m +103%
Equity 10/15 €2,043,340 €4,496,430 +€2.5m +120%
Contributions 10/11 €18,550 €18,550 = 0.0%
Reserves 13 €1,855 €1,855 = 0.0%
Non-distributable reserves 130/1 €1,855 €1,855 = 0.0%
Reserves not available under the articles 1311 €1,855 €1,855 = 0.0%
Profit (loss) carried forward 14 €2,022,935 €4,476,025 +€2.5m +121%
Amounts payable 17/49 €533,009 €738,502 +€205,493 +38.6%
Amounts payable within one year 42/48 €533,009 €738,502 +€205,493 +38.6%
Trade debts 44 €432,536 €738,502 +€305,966 +70.7%
Suppliers 440/4 €432,536 €738,502 +€305,966 +70.7%
Other amounts payable 47/48 €100,473 - -€100,473
Operating income 70/76A €27,359,485 €30,041,151 +€2.7m +9.8%
Turnover 70 €27,359,485 €30,041,151 +€2.7m +9.8%
Operating charges 60/66A €24,725,029 €26,792,476 +€2.1m +8.4%
Goods for resale, raw materials and consumables 60 €22,590,355 €24,367,335 +€1.8m +7.9%
Purchases 600/8 €23,173,667 €26,158,794 +€3.0m +12.9%
Change in stocks: decrease (increase) 609 -€583,312 -€1,791,459 -€1.2m -207%
Services and other goods 61 €2,099,677 €2,404,541 +€304,864 +14.5%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €33,890 €19,311 -€14,579 -43.0%
Other operating charges 640/8 €1,107 €1,289 +€182 +16.4%
Operating profit (loss) 9901 €2,634,456 €3,248,675 +€614,219 +23.3%
Financial income 75/76B €4,179 €24,453 +€20,274 +485%
Recurring financial income 75 €4,166 €24,453 +€20,287 +487%
Income from financial fixed assets 750 €3,030 €23,921 +€20,891 +689%
Other financial income 752/9 €1,136 €532 -€604 -53.2%
Non-recurring financial income 76B €13 - -€13
Financial charges 65/66B €32,387 €2,294 -€30,093 -92.9%
Recurring financial charges 65 €32,296 €2,279 -€30,017 -92.9%
Debt charges 650 €32,296 €2,279 -€30,017 -92.9%
Non-recurring financial charges 66B €91 €15 -€76 -83.5%
Profit (loss) for the period before taxes 9903 €2,606,248 €3,270,834 +€664,586 +25.5%
Income taxes 67/77 €651,637 €817,745 +€166,108 +25.5%
Taxes 670/3 €651,637 €817,745 +€166,108 +25.5%
Profit (loss) for the period 9904 €1,954,611 €2,453,089 +€498,478 +25.5%
Profit (loss) for the period to be appropriated 9905 €1,954,611 €2,453,089 +€498,478 +25.5%

Source: filed annual accounts (NBB), financial years ended 31 January 2025 and 31 January 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.